|
33
|
114
|
8sonA |
Crystal structure of macrophage migration inhibitory factor in complex with n-[3-(trifluoromethyl)phenyl]-3-(2-chloroanilino)-2-cyano-3-thioxopropanamide |
|
28
|
108
|
7u8dA |
Fkbp12 mutant v55g bound to rapa*-3z |
|
49
|
163
|
7tguX |
Structure of cyclophilin d peptidyl-prolyl isomerase domain bound to macrocyclic inhibitor b1 |
|
51
|
163
|
7thfA |
Structure of cyclophilin d peptidyl-prolyl isomerase domain bound to macrocyclic inhibitor b53 |
|
53
|
164
|
7tgvX |
Structure of cyclophilin d peptidyl-prolyl isomerase domain bound to macrocyclic inhibitor b2 |
|
131
|
357
|
7mqxA |
P. putida mandelate racemase forms an oxobenzoxaborole adduct with 2-formylphenylboronic acid |
|
48
|
158
|
6vajA |
Crystal structure analysis of human pin1 |
|
51
|
165
|
6x4qA |
Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-14-cyclobutyl-2,11,17,17-tetramethyl-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 33) |
|
55
|
165
|
6x4pA |
Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-2,11,17,17-tetramethyl-14-(propan-2-yl)-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 28) |
|
52
|
167
|
6x4mA |
Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: tert-butyl [(2s)-1-{[(3s,17s)-2,16-dioxo-10,15-dioxa-1,21-diazatricyclo[15.3.1.1~5,9~]docosa-5(22),6,8-trien-3-yl]amino}-3-methyl-1-oxobutan-2-yl]carbamate (compound 3) |
|
51
|
163
|
6x4oA |
Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-2,11-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,21,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(26),18,20,22,24,27-hexaene-4,10,13,16-tetrone (compound 21) |
|
49
|
165
|
6x4nA |
Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-2,11,17,17-tetramethyl-14-(propan-2-yl)-3-oxa-9,12,15,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 24) |
|
54
|
163
|
6x3rA |
Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors |
|
51
|
166
|
6x3yA |
Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors |
|
97
|
297
|
6p13B |
Structure of spastin aaa domain (t692a mutant) in complex with a diaminotriazole-based inhibitor (crystal form a) |
|
91
|
296
|
6p11B |
Structure of spastin aaa domain (t692a mutant) in complex with jnj-7706621 inhibitor |
|
97
|
296
|
6p12B |
Structure of spastin aaa domain (wild-type) in complex with diaminotriazole-based inhibitor |
|
94
|
300
|
6p14A |
Structure of spastin aaa domain (t692a mutant) in complex with a diaminotriazole-based inhibitor (crystal form b) |
|
93
|
296
|
6p10B |
Structure of spastin aaa domain (n527c mutant) in complex with jnj-7706621 inhibitor |
|
65
|
148
|
5k0iA |
Mpges1 bound to an inhibitor |
|
34
|
114
|
5hvtA |
Crystal structure of macrophage migration inhibitory factor (mif) with a potent inhibitor (nvs-2) |
|
34
|
114
|
5hvsA |
Crystal structure of macrophage migration inhibitory factor (mif) with a biaryltriazole inhibitor (3i-305) |
|
34
|
114
|
6cb5A |
Macrophage migration inhibitory factor in complex with a pyrazole inhibitor (8g) |
|
35
|
114
|
6b1kA |
Macrophage migration inhibitory factor in complex with a naphthyridinone inhibitor (3a) |
|
36
|
114
|
6b1cA |
Macrophage migration inhibitory factor in complex with a naphthyridinone inhibitor (4a) |
|
31
|
114
|
6b2cA |
Macrophage migration inhibitory factor in complex with a naphthyridinone inhibitor (4b) |
|
58
|
210
|
5bodA |
Crystal structure of streptococcus pneumonia pare inhibitor |
|
64
|
148
|
5bqhA |
Discovery of a potent and selective mpges-1 inhibitor for the treatment of pain |
|
66
|
148
|
5bqiA |
Discovery of a potent and selective mpges-1 inhibitor for the treatment of pain |
|
31
|
113
|
4z15A |
Mif in complex with 3-(2-furylmethyl)-2-thioxo-1,3-thiazolan-4-one |
|
31
|
113
|
4z1uA |
Mif in complex with 1-(4-methylphenyl)-3-phenylprop-2-yn-1-one |
|
32
|
113
|
4z1tA |
Mif in complex with 4-[(4-oxo-2-thioxo-1,3-thiazolan-3-yl)methyl]benzonitrile |
|
52
|
164
|
4totA |
Crystal structure of rat cyclophilin d in complex with a potent nonimmunosuppressive inhibitor |
|
34
|
114
|
4f2kA |
Macrophage migration inhibitory factor covalently complexed with phenethylisothiocyanate |
|
70
|
198
|
4edzA |
Crystal structure of hh-pgds with water displacing inhibitor |
|
73
|
198
|
4edyA |
Crystal structure of hh-pgds with water displacing inhibitor |
|
142
|
388
|
4duoA |
Room-temperature x-ray structure of d-xylose isomerase in complex with 2mg2+ ions and xylitol at ph 7.7 |
|
57
|
210
|
4em7A |
Crystal structure of a topoisomerase atp inhibitor |
|
56
|
203
|
4duhA |
Crystal structure of 24 kda domain of e. coli dna gyrase b in complex with small molecule inhibitor |
|
73
|
199
|
4ec0A |
Crystal structure of hh-pgds with water displacing inhibitor |
|
71
|
198
|
4ee0A |
Crystal structure of hh-pgds with water displacing inhibitor |
|
57
|
210
|
4emvA |
Crystal structure of a topoisomerase atp inhibitor |
|
35
|
114
|
3wntA |
Multiple binding modes of benzyl isothiocyanate inhibitor complexed with macrophage migration inhibitory factor |
|
34
|
114
|
3wnsA |
Allyl isothiocyanate inhibitor complexed with macrophage migration inhibitory factor |
|
35
|
114
|
3wnrA |
Multiple binding modes of benzyl isothiocyanate inhibitor complexed with macrophage migration inhibitory factor |
|
68
|
198
|
3vi5A |
Human hematopoietic prostaglandin d synthase inhibitor complex structures |
|
75
|
198
|
3vi7A |
Human hematopoietic prostaglandin d synthase inhibitor complex structures |
|
63
|
194
|
3u2dA |
S. aureus gyrb atpase domain in complex with small molecule inhibitor |
|
62
|
194
|
3ttzA |
Crystal structure of a topoisomerase atpase inhibitor |
|
64
|
194
|
3u2kA |
S. aureus gyrb atpase domain in complex with a small molecule inhibitor |
